"I am particularly pleased to welcome Christine to the Insmed team. Having worked with Christine while at Aegerion, I know first-hand that she will be an invaluable asset to the Company. Christine has broad legal experience with both development and commercial stage pharmaceutical companies. Her significant leadership experience will provide new insight and valuable perspective as we look to transition the Company to a commercial entity and build Insmed into a leading biopharmaceutical company," said Will Lewis, President and CEO of Insmed.
"It is a pleasure to be joining the Insmed team at this important juncture in the Company's development. The Company's focus on developing new therapeutics for unmet medical needs at the intersection of pulmonary, infectious and orphan diseases offers a very exciting opportunity. I look forward to being a part of this dynamic leadership team as we bring new treatments to patients suffering from these serious lung diseases," commented Ms. Pellizzari
Why anyone would thumb down info shows they are angry!....So Will fired the other gal and brought in a former pal from Aegerion( where Will was let go )...last time, they hired an Attorney, the rat data was released.... sounds like we are setting up for another SEC case!!!. my ignore is on hi - )
I am not certain why all the abuse. The CEO is obviously able to attract talent he's worked with, and from a company with a related business model that has done well. It seems like a fit and a great hire for what seems the #2 corporate role. One could view this as a sign of confidence rather than concern. JMO